2019
DOI: 10.36062/ijah.58.1.2019.79-86
|View full text |Cite
|
Sign up to set email alerts
|

Incidence of canine parvovirus infection of dogs in Andhra Pradesh

Abstract: The present study was conducted on the incidence studies of the canine parvovirus (CPV) infection from different parts of Andhra Pradesh, India. A total of three hundred and forty two (n=342) canine parvovirus suspected clinical faecal samples of different age group of dogs from both vaccinated and non-vaccinated animals were collected. The faecal samples were preliminarily screened by haemagglutination assay and further confirmation by employing polymerase chain reaction (PCR). Dogs of age group below four mo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 14 publications
0
1
0
Order By: Relevance
“…In the present study, the CPV-2 viral isolate required only one passage on MDCK cells for its adaptation and production of CPE indicative of the highly cytopathic nature of isolated CPV-2. CPV-2 and its variants are being reported in India (Kaur et al, 2015;Sharma et al, 2018;Kumari et al, 2019). The highly cytopathic CPV-2 strain was further characterized at its molecular level as CPV-2a in the amplification refractory mutation system-polymerase chain reaction test (Chander et al, 2016) (National Centre for Biotechnology Information Accession Number: MZ209401).…”
Section: Resultsmentioning
confidence: 99%
“…In the present study, the CPV-2 viral isolate required only one passage on MDCK cells for its adaptation and production of CPE indicative of the highly cytopathic nature of isolated CPV-2. CPV-2 and its variants are being reported in India (Kaur et al, 2015;Sharma et al, 2018;Kumari et al, 2019). The highly cytopathic CPV-2 strain was further characterized at its molecular level as CPV-2a in the amplification refractory mutation system-polymerase chain reaction test (Chander et al, 2016) (National Centre for Biotechnology Information Accession Number: MZ209401).…”
Section: Resultsmentioning
confidence: 99%